Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

'15 Days To Slow the Spread': On the Fourth Anniversary, a Reminder to Never Give Politicians That Power Again

In the name of safety, politicians did many things that diminished our lives—without making us safer.

The way we name cancers could affect access to treatment, researchers say

The way we name cancers could affect access to treatment, researchers say

Revamping cancer classification to focus on molecular characteristics over organ of origin can result in more effective and timely treatment, a group of doctors has said.

Lawsuits Against Gilead Sciences Could Stifle Medical Innovation

Lawsuits Against Gilead Sciences Could Stifle Medical Innovation

Lawsuit against Gilead Sciences raises concerns about innovation impact in drug development and potential implications on future product development.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Many pharma companies that bought electoral bonds faced regulatory actions

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

Despite bans in some states, more than a million abortions were provided in 2023

That's the highest number in more than a decade, according to new research. Medication abortion made up a larger share of the total than in 2020.

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

From anxiety to cancer, the evidence against ultra-processed food piles up

Americans consume more than half their daily calories from ultra-processed food. A new study finds consuming lots of this food is linked to a higher risk of many diseases.

inkl

Read news from The Economist, FT, and more,
with one subscription

California may ban some food dyes in school meals. Will other states follow?

California may ban some food dyes in school meals. Will other states follow?

Consumer groups say it’s past time to rid food of unnecessary and potentially harmful chemicals

The Guardian - US

After a Century, the Federal Tea Board Is Finally Dead

Imported tea was required for decades to pass a literal taste test before it could be sold in the United States.

Could decaf coffee be banned?

Could decaf coffee be banned?

Some activists and lawmakers want to ban European Method decaf, the most common form of decaffeinated coffee

Indian team uses repurposed drug to treat oral cancer subtype

Indian team uses repurposed drug to treat oral cancer subtype

Mumbai researchers identify fusion transcript in head and neck cancer, propose deworming drug pyrvinium pamoate as treatment.

Meta's Role In Illegal Drug Sales Under Federal Investigation: Report

Meta's Role In Illegal Drug Sales Under Federal Investigation: Report

The paper quoted a spokesman for Meta as saying in a statement: "The sale of illicit drugs is against our policies and we work to find and remove this content from our services".

International Business Times

Stocks Settle Lower as Bond Yields Climb on Inflation Concerns

Stocks Settle Lower as Bond Yields Climb on Inflation Concerns

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.65%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.15%. Stocks on Friday posted moderate losses, with the Nasdaq 100 falling to a 3-week...

Stocks Under Pressure as Bond Yields Climb

Stocks Under Pressure as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stocks this morning are moderately lower, with the Nasdaq 100 falling to a...

Get all your
news in one place.

100’s of premium titles.
One news app.

These Celebrities Admitted To Taking Ozempic, And Some Had Terrible Side Effects

Though the drug only received FDA approval for the treatment of type 2 diabetes, these high-profile individuals have used it for weight loss. Some quit after a few weeks. The post These Celebrities Admitted To Taking Ozempic, And Some Had Terrible Side Effects first appeared on Bored Panda.

International Business Times

US Approves First Drug For Severe Form Of Fatty Liver Disease

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

International Business Times

Cancer Patients In The Philippines Falling For Alternative 'Cures'

Filipino single mother Mary Ann Eduarte delayed chemotherapy for her breast cancer for several years and instead took food supplements falsely promoted on social media as cures for the deadly disease.

The Guardian - US

Most US sandwich baggies contain toxic PFAS ‘forever chemicals’, analysis says

Testing commissioned by Mamavation blog found high levels of a marker of PFAS in nine of 11 baggies tested

Get all your
news in one place.

100’s of premium titles.
One news app.

1 AI Growth Stock With 54% Upside Potential

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.

Here are the concerns with artificial food dyes, as California weighs a ban in schools

Six artificial food dyes and titanium dioxide would be banned in schools under a proposal in the state legislature. Critics say there isn't enough evidence to prove they're a health risk.

A simple blood test can detect colorectal cancer early, study finds

At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection.

Growing teen THC use could further complicate cannabis policy - Roll Call

Adolescents are using an often unregulated, psychoactive derivative of cannabis, according to national data released Wednesday.

Abortion Pill Studies Retracted: Politics or Science?

"Following the science" as the Supreme Court considers the safety and efficacy of medical abortions.

COVID patients can't get Paxlovid

The price is one reason Paxlovid is not reaching those who need it most

The Texas Tribune

Why covid patients who could most benefit from paxlovid still aren’t getting it

During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.

1 … 87 88 89 90

People

161,415 stories

Matthew Kacsmaryk

William Schaffner

Keith Humphreys

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Supreme Court

Harvard University

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

331,957 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play